Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders

Medical cannabis products show limited evidence of effectiveness in treating most mental health and substance use disorders, according to a pooled analysis of 54 studies.

Across the studies, which included 2,477 participants, use of cannabinoids—including cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC)—was not associated with significant reductions in symptoms for conditions such as anxiety disorders, post-traumatic stress disorder, psychotic disorders, anorexia nervosa, or opioid use disorder. No studies in the analysis reported outcomes for depression.

Cannabinoid use was associated with a higher risk of adverse events compared to placebo, although there was no increase in serious . . .